Validation of drug-like inhibitors against Mycobacterium tuberculosis L-aspartate α-decarboxylase using nuclear magnetic resonance (1H NMR).
The catalytic activity of L-aspartate α-decarboxylase (ADC) is essential for the growth of several micro-organisms, including Mycobacterium tuberculosis (Mtb), and has triggered efforts for the development of pharmaceutically active compounds against tuberculosis. The present study is a continuation...
Guardado en:
Autores principales: | Reetu Sharma, Mara Florea, Werner M Nau, Kunchithapadam Swaminathan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a179f203babc4c89b292f030b11b9f82 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chemoinformatic identification of novel inhibitors against Mycobacterium tuberculosis L-aspartate α-decarboxylase.
por: Reetu Sharma, et al.
Publicado: (2012) -
Pyrazinamide triggers degradation of its target aspartate decarboxylase
por: Pooja Gopal, et al.
Publicado: (2020) -
Aspartate aminotransferase Rv3722c governs aspartate-dependent nitrogen metabolism in Mycobacterium tuberculosis
por: Robert S. Jansen, et al.
Publicado: (2020) -
Derailing the aspartate pathway of Mycobacterium tuberculosis to eradicate persistent infection
por: Erik J. Hasenoehrl, et al.
Publicado: (2019) -
PanM, an Acetyl-Coenzyme A Sensor Required for Maturation of <sc>l</sc>-Aspartate Decarboxylase (PanD)
por: Tara N. Stuecker, et al.
Publicado: (2012)